Graham P. Allaway
Geen lopende functies
Loopbaan van Graham P. Allaway
Eerdere bekende functies van Graham P. Allaway
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Operationeel Directeur | 27-02-2009 | 27-02-2009 |
| Oprichter | 01-12-1992 | 27-02-2009 | |
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Operationeel Directeur | 03-03-2005 | 03-03-2005 |
| President | - | 03-03-2005 | |
Manchester Biotech
 Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | President | 01-01-1997 | 01-01-1998 |
| PRESSURE BIOSCIENCES, INC. | Corporate Officer/Principal | 26-11-2009 | - |
Opleiding van Graham P. Allaway
| University of Oxford | Graduate Degree |
| University of London | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 3 |
Operationeel
| President | 2 |
| Chief Operating Officer | 2 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Manchester Biotech
Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Health Technology |
Panacos Pharmaceuticals, Inc. /Old/
Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
- Beurs
- Insiders
- Graham P. Allaway
- Ervaring
